secwatch.observer — SEC 8-K summary
======================================

Issuer:     SeaStar Medical Holding Corp (ICU)
CIK:        0001831868
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0000950170-25-093142
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SeaStar Medical regains Nasdaq equity compliance; needs funds by end of July
----------------------------------------------------------------------------

- Confirmed compliance with Nasdaq's $2.5M minimum stockholders' equity requirement; listing matter closed.
- Nasdaq warned company must raise additional funds or will be below requirement by end of July 2025.
- Subject to Mandatory Panel Monitor until July 1, 2026; future non-compliance may trigger delist determination.
- CEO Schloff highlights focus on commercializing QUELIMMUNE and NEUTRALIZE-AKI trial for AKI patients.
- Company previously received Panel exception through June 22, 2025; compliance now evidenced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831868/000095017025093142/0000950170-25-093142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831868/000095017025093142/icu-20250701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-093142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer